Author:
Wong Judith J. M.,Yeo Angela S. H.,Buang Siti N. H.,Chan Yoke Hwee
Publisher
Springer International Publishing
Reference64 articles.
1. Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018;70(3):621–60. PubMed PMID: 29945898. Pubmed Central PMCID: PMC6020109. Epub 2018/06/28. eng.
2. Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci. 1982;71(5):539–42. PubMed PMID: 7097501. Epub 1982/05/01. eng.
3. Rolan P, Lim S, Sunderland V, Liu Y, Molnar V. The absolute bioavailability of racemic ketamine from a novel sublingual formulation. Br J Clin Pharmacol. 2014;77(6):1011–6. PubMed PMID: 24977293. Pubmed Central PMCID: PMC4093926. Epub 2014/07/01. eng.
4. Malinovsky JM, Servin F, Cozian A, Lepage JY, Pinaud M. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth. 1996;77(2):203–7. PubMed PMID: 8881626. Epub 1996/08/01. eng.
5. Hornik CP, Gonzalez D, van den Anker J, Atz AM, Yogev R, Poindexter BB, et al. Population pharmacokinetics of intramuscular and intravenous ketamine in children. J Clin Pharmacol. 2018. PubMed PMID: 29677389. Pubmed Central PMCID: PMC6195858. Epub 2018/04/21. eng.